Clinical Trials

20 enrolled

Triple Negative Breast Neoplasms

NCT06008158 2025-12-10

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Phase 2 Suspended

48 enrolled

Breast Carcinoma In Situ

NCT05315011 2025-12-03

CRYOMATASE

70 enrolled

Breast Neoplasms, Arthralgia

NCT07178665 2025-11-14

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

98 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05958199 2025-06-27

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

131 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT06491654 2025-06-11

Physiotherapy Program Impact on Breast Cancer-Related Lymphedema

21 enrolled

Breast Cancer Lymphedema, Breast Neoplasms, Lymphedema

NCT06121453 2025-05-22

Adherence Intervention in Patients With Metastatic Breast Cancer

35 enrolled

Breast Neoplasms

NCT04973930 2025-05-13

IPT

20 enrolled

Breast Neoplasms, Depressive Disorder, Major

NCT06214793 2025-05-01

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Phase 2 Suspended

61 enrolled

Breast Neoplasms

NCT04339517 2025-03-28

Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer

20 enrolled

Breast Neoplasms

NCT04151368 2025-01-31

RNSM

30 enrolled

Breast Diseases, Breast Neoplasms, Genetic Predisposition to Disease

NCT05076591 2024-10-30

IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors

BreastGastrointestinalOther solid neoplasm

135 enrolled

Advanced Solid Tumor

NCT02037529 2024-08-20

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

201 enrolled 19 charts

Breast Neoplasms

NCT04946864 2024-08-19

A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer

Phase 1/2 Suspended

65 enrolled

Breast Neoplasms

NCT04120246 2024-07-10

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

24 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

BreastDermatologicGastrointestinalGenitourinarySarcoma

30 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT05503108 2023-11-22

DIRECT-2

10 enrolled

Fasting Mimicking Diet

NCT03002103 2023-04-26

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

420 enrolled

Triple Negative Breast Neoplasms

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

220 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT03130946 2022-10-18

Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes

135 enrolled

Breast Neoplasms

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors